Arthritis drug shortage looms

empty shelves
TGA working with wholesalers to restrict available Actemra stock to community pharmacies and hospitals as stocks dwindle Australia faces a shortage of arthritis drug Actemra (tocilizumab) following recommendation by the World Health Organisation as treatment for patients seriously ill COVID-19. Shortages of some iterations of the interleukin-6 (IL6) receptor blocker class drug may, in some

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Clinical tips: Self-diagnosed thrush
Next The children's asthma conundrum